...
首页> 外文期刊>Blood: The Journal of the American Society of Hematology >In vivo expansion of cells expressing acquired CSF3R mutations in patients with severe congenital neutropenia.
【24h】

In vivo expansion of cells expressing acquired CSF3R mutations in patients with severe congenital neutropenia.

机译:患有严重先天性中性粒细胞减少症的患者中表达获得性CSF3R突变的细胞的体内扩增。

获取原文
获取原文并翻译 | 示例

摘要

Severe congenital neutropenia (CN) is a rare bone marrow failure syndrome with a high incidence of acute leukemia. In previous studies, we could show that point mutations in the gene for the granulocyte colony-stimulating factor (G-CSF) receptor CSF3R are a highly predictive marker for leukemic development in CN patients. To find out at which stage of hematopoietic development these mutations emerge and how they are propagated during hematopoietic differentiation, we analyzed single cells of different hematopoietic subpopulations from CN patients with CSF3R mutations. We found that CSF3R mutations are not restricted to the myeloid compartment but are also detectable in lymphoid cells, although at a much lower percentage. From our observations, we conclude that CSF3R mutations are acquired in multipotent hematopoietic progenitor cells in CN patients and that they are clonally expanded in myeloid cells expressing the G-CSF receptor due to the growth advantage mediated by the CSF3R mutation.
机译:严重的先天性中性粒细胞减少症(CN)是一种罕见的骨髓衰竭综合征,急性白血病的发生率很高。在以前的研究中,我们可以证明粒细胞集落刺激因子(G-CSF)受体CSF3R的基因中的点突变是CN患者白血病发展的高度预测性标志物。为了找出这些突变出现在造血发育的哪个阶段以及它们在造血分化过程中如何传播,我们分析了具有CSF3R突变的CN患者不同造血亚群的单个细胞。我们发现,CSF3R突变不仅限于髓样区,而且在淋巴样细胞中也可以检测到,尽管百分比要低得多。从我们的观察中,我们得出结论,CSF3R突变是在CN患者的多能造血祖细胞中获得的,并且由于CSF3R突变介导的生长优势,它们在表达G-CSF受体的髓样细胞中克隆扩增。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号